Finance

Beta
Lists
PRME:NASDAQ
Prime Medicine, Inc
$2.88
-2.70%
(-0.080) 1D
$2.88
0.00% (0.00)
After hours
Closed: Jun 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRME...
Open
$2.99
High
$3.05
Low
$2.78
Mkt. cap
520.18M
Avg. vol.
2.67M
Volume
0.00
52-wk high
$6.94
52-wk low
$1.40
EPS
-$1.26
Beta
2.31
Shares outstanding
180.62M
No. of employees
146
Open
$2.99
High
$3.05
Low
$2.78
Mkt. cap
520.18M
Avg. vol.
2.67M
Volume
0.00
52-wk high
$6.94
52-wk low
$1.40
EPS
-$1.26
Beta
2.31
Shares outstanding
180.62M
No. of employees
146
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to PRME in the past 3 months
Strong Buy
Buy
6
Hold
2
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for PRME in the last 3 months.
Highest
Current $2.88
$11.00 (+281.94%)
Average
$7.80 (+170.83%)
Lowest
$5.00 (+73.61%)
News stories
From sources across the web
Profile
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts. Wikipedia
About Prime Medicine, Inc
CEO-
Employees146
Founded2019
Headquarters-
SectorBiotechnology
Websiteprimemedicine.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.12M
1.22M
838.00K
856.00K
Cost of goods sold
3.22M
43.99M
34.71M
34.10M
Cost of revenue
3.22M
43.99M
34.71M
34.10M
Research and development expenses
38.16M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.12M
11.21M
14.74M
17.40M
Operating expense
51.27M
11.21M
14.74M
17.40M
Total operating expenses
54.49M
55.20M
49.45M
51.51M
Operating income
-53.38M
-53.97M
-48.61M
-50.65M
Other non operating income
18.00K
44.00K
49.00K
51.00K
EBT including unusual items
-52.59M
-50.58M
-46.08M
-49.12M
EBT excluding unusual items
-52.62M
-52.79M
-47.48M
-49.58M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-52.59M
-50.58M
-46.08M
-49.12M
Net profit margin
-4,716.68%
-4,129.14%
-5,498.69%
-5,738.55%
Earnings per share
-0.41
-0.32
-0.24
-0.28
Interest and investment income
743.00K
1.14M
1.08M
1.02M
Interest expense
-
-
-
-
Net interest expenses
743.00K
1.14M
1.08M
1.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
-51.51M
-52.09M
-46.73M
-48.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer